{"nct_id":"NCT02413489","title":"An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2015-09-02","start_date_type":"ACTUAL","primary_completion_date":"2017-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2017-06-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}